Simon Read

Simon serves as Chief Executive Officer of Mariana Oncology. He is Founder, President and a member of the Board of Directors. Before founding Mariana Oncology, Simon was Entrepreneur-in-Residence at Atlas Venture. Prior to this, Simon was CSO at Ra Pharma (NASDAQ: RARX) until its acquisition by UCB Pharma. Simon brings to Mariana more than 25 years of R&D experience including leadership roles at GlaxoSmithKline, AstraZeneca and Roche/Genentech. Simon has worked on the clinical development of some of the most widely used drugs in the industry including Rituxan® and Actemra®.

More broadly, Simon is Co-Founder and Board member of Triana Biomedicines. He is a Scientific Advisory Board member of Q32 Bio and a Fellow of the Royal Society of Medicine. He obtained his Ph.D. from University of Hertfordshire and studied Physiology at the University of Manchester in the UK. Simon is well published, having authored over 50 peer reviewed articles and patents.